Abstract
The constitutive activation of β-catenin-dependent (‘canonical’) Wnt signalling is a necessary initiating event in the genesis of most colorectal cancers. As this constitutive activation occurs through genetic mutation of one of the down-stream components of the signalling pathway, it was presumed that additional regulation of β-catenin-dependent Wnt signalling would be inconsequential. However, it is now recognised that additional modulation of β-catenin-dependent Wnt signalling is involved in tumour progression, and many of the genes associated with tumour invasion and metastasis are β-catenin/TCF transcriptional target genes that are dynamically regulated during cancer progression. Intriguingly, the demonstration that naturally occurring inhibitors of Wnt-Frizzled (FZD) interaction are bona fide tumour suppressors in this cancer suggests that additional modulation of Wnt signalling is via the upstream components of the pathway. This is corroborated by recent studies that demonstrate tumour-promoting roles for Wnt and FZD per se. Moreover, both β-catenin-dependent and β-catenin-independent Wnt/FZD-mediated signalling is implicated during the dynamic and reversible EMT and MET that underscore colorectal cancer progression. Importantly, therapeutic targeting of the Wnt signalling pathway at the plasma membrane is clearly indicated by the profound anti-tumour activity of small molecule inhibitors and dominant-negative receptor constructs that target the receptor complex. The potential to effectively target EMT and MET processes at the plasma membrane via the upstream components of the Wnt signalling pathway offers new hope for anti-cancer therapy.
Similar content being viewed by others
References
NCI (http://www.cancer.gov/cancertopics/types/colon-and-rectal)
Brabletz T, Jung A, Spaderna S et al (2005) Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744–749
Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480
van de Wetering M, Sancho E, Verweij C et al (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250
Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142
Brabletz T, Jung A, Reu S et al (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98:10356–10361
Vincan E, Darcy PK, Smyth MJ et al (2005) Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation 73:142–153
Fujii N, You L, Xu Z et al (2007) An antagonist of dishevelled protein–protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res 67:573–579
DeAlmeida VI, Miao L, Ernst JA et al (2007) The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res 67:5371–5379
You L, He B, Xu Z et al (2004) An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 64:5385–5389
Aguilera O, Fraga MF, Ballestar E et al (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25:4116–4121
Caldwell GM, Jones C, Gensberg K et al (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64:883–888
Suzuki H, Watkins DN, Jair KW et al (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417–422
Cadigan KM, Liu YI (2006) Wnt signaling: complexity at the surface. J Cell Sci 119:395–402
Bilic J, Huang YL, Davidson G et al (2007) Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316:1619–1622
Rubin JS, Barshishat-Kupper M, Feroze-Merzoug F et al (2006) Secreted Wnt antagonists as tumour supressors: pro and con. Front Biosci 11:2093–2105
Veeman MT, Axelrod JD, Moon RT (2003) A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5:367–377
Slusarski DC, Pelegri F (2007) Calcium signaling in vertebrate embryonic patterning and morphogenesis. Dev Biol 307:1–13
Saburi S, McNeill H (2005) Organising cells into tissues: new roles for cell adhesion molecules in planar cell polarity. Curr Opin Cell Biol 17:482–488
Vinson CR, Conover S, Adler PN (1989) A Drosophila tissue polarity locus encodes a protein containing seven potential transmembrane domains. Nature 338:263–264
Mikels AJ, Nusse R (2006) Wnts as ligands: processing, secretion and reception. Oncogene 25:7461–7468
Potter JD (2007) Morphogens, morphostats, microarchitecture and malignancy. Nat Rev Cancer 7:464–474
Rubinfeld B, Souza B, Albert I et al (1993) Association of the APC gene product with beta-catenin. Science 262:1731–1734
Morin PJ, Sparks AB, Korinek V et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790
Korinek V, Barker N, Morin PJ et al (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784–1787
Gregorieff A, Clevers H (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19:877–890
Sansom OJ, Reed KR, Hayes AJ et al (2004) Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18:1385–1390
Korinek V, Barker N, Moerer P et al (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379–383
Pinto D, Gregorieff A, Begthel H et al (2003) Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 17:1709–1713
Kuhnert F, Davis CR, Wang HT et al (2004) Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci USA 101:266–271
Batlle E, Henderson JT, Beghtel H et al (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251–263
Taketo MM (2006) Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 25:7522–7530
Brabletz T, Jung A, Hermann K et al (1998) Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194:701–704
Kirchner T, Brabletz T (2000) Tumor patterning: analogies of neoplastic morphogenesis with embryogenesis. Verh Dtsch Ges Pathol 84:22–27
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767
Munoz R, Moreno M, Oliva C et al (2006) Syndecan-4 regulates non-canonical Wnt signalling and is essential for convergent and extension movements in Xenopus embryos. Nat Cell Biol 8:492–500
Spencer VA, Xu R, Bissell MJ (2007) Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. Adv Cancer Res 97:275–294
Dimitriadis A, Vincan E, Mohammed IM et al (2001) Expression of Wnt genes in human colon cancers. Cancer Lett 166:185–199
Vincan E (2004) Frizzled/WNT signalling: the insidious promoter of tumour growth and progression. Front Biosci 9:1023–1034
Vincan E, Darcy PK, Farrelly CA et al (2007) Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene 26:2340–2352
Holcombe RF, Marsh JL, Waterman ML et al (2002) Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 55:220–226
He B, Reguart N, You L et al (2005) Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24:3054–3058
Xu XL, Yu J, Zhang HY et al (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10:3441–3454
Taniguchi H, Yamamoto H, Hirata T et al (2005) Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24:7946–7952
You L, Kim J, He B et al (2006) Wnt-1 signal as a potential cancer therapeutic target. Drug News Perspect 19:27–31
Zi X, Guo Y, Simoneau AR et al (2005) Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 65:9762–9770
Winklbauer R, Medina A, Swain RK et al (2001) Frizzled-7 signalling controls tissue separation during Xenopus gastrulation. Nature 413:856–860
Medina A, Reintsch W, Steinbeisser H (2000) Xenopus frizzled 7 can act in canonical and non-canonical Wnt signaling pathways: implications on early patterning and morphogenesis. Mech Dev 92:227–237
Kemp CR, Willems E, Wawrzak D et al (2007) Expression of Frizzled5, Frizzled7, and Frizzled10 during early mouse development and interactions with canonical Wnt signaling. Dev Dyn 236:2011–2019
Minobe S, Fei K, Yan L et al (2000) Identification and characterization of the epithelial polarity receptor “Frizzled” in Hydra vulgaris. Dev Genes Evol 210:258–262
Sagara N, Toda G, Hirai M et al (1998) Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7. Biochem Biophys Res Commun 252:117–122
Gregorieff A, Pinto D, Begthel H et al (2005) Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129:626–638
Wang Y, Guo N, Nathans J (2006) The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J Neurosci 26:2147–2156
Witzel S, Zimyanin V, Carreira-Barbosa F et al (2006) Wnt11 controls cell contact persistence by local accumulation of Frizzled 7 at the plasma membrane. J Cell Biol 175:791–802
Song MR, Shirasaki R, Cai CL et al (2006) T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration. Development 133:4945–4955
Vincan E, Swain RK, Brabletz T et al (2007) Frizzled7 dictates embryonic morphogenesis: implications for colorectal cancer progression. Front Biosci 12:4558–4567
Iglesias DM, Hueber PA, Chu L et al (2007) Canonical WNT signaling during kidney development. Am J Physiol Renal Physiol 293:F494–F500
Katoh M, Hirai M, Sugimura T et al (1996) Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family. Oncogene 13:873–876
Shi Y, He B, Kuchenbecker KM et al (2007) Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 121:1175–1181
Barker N, Clevers H (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 12:997–1014
Acknowledgement
This work was supported, in part, by a grant-in-aid from the Cancer Council of Victoria (to EV).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vincan, E., Barker, N. The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin Exp Metastasis 25, 657–663 (2008). https://doi.org/10.1007/s10585-008-9156-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-008-9156-4